Fecal Microbiota Transplantation for Epilepsy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02889627|
Recruitment Status : Unknown
Verified May 2017 by Faming Zhang, The Second Hospital of Nanjing Medical University.
Recruitment status was: Recruiting
First Posted : September 5, 2016
Last Update Posted : April 2, 2019
The Second Hospital of Nanjing Medical University
Information provided by (Responsible Party):
Faming Zhang, The Second Hospital of Nanjing Medical University
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||September 2019|
|Estimated Study Completion Date :||September 2019|
Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, Patterson PH, Mazmanian SK. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013 Dec 19;155(7):1451-63. doi: 10.1016/j.cell.2013.11.024. Epub 2013 Dec 5.
Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol. 2011 Dec 20;9(2):88-96. doi: 10.1038/nrgastro.2011.244. Review.